Cuvposa (glycopyrrolate)

pCPA File Number: 21261

Negotiation Status:

Concluded with an LOI

Indication(s):

Pediatric chronic severe drooling reduction (neurologic)

Sponsor/Manufacturer:

Medexus Pharmaceuticals, Inc.

CDA-AMC Project Number:

SR0613-000

pCPA Engagement Letter Issued:

2022-10-24

Negotiation Process Concluded:

2023-01-16